Topic: Chutes and Ladders
The appointment ends Zelenkofske’s brief time as chief medical officer of uniQure, the company he joined last summer from AstraZeneca.
Gilead CMO quits six months after taking job; Allergan taps Pfizer vet as CMO; and Novartis recruits Siemens ethics chief as it reels from scandal.
Pharma veteran Geno Germano is taking the CEO spot at Elucida Oncology, which is developing a nanoparticle platform to diagnose and treat cancer.
Acorda's chief technology officer Rick Batycky, Ph.D., is leaving the company next week after four years in the role to head up his own operation.
CAR-T player Cellectis poached a Novartis exec; GSK recruited a CFO to spearhead cost-cutting; Thomas Hughes leaves Zafgen to lead Navitor; and more.
CAR-T maker Cell Medica names Kite’s European chief as CEO; Oncorus poaches a Moderna cancer executive; and Achaogen axes R&D and its C-suite.
Gilead's top executives step down, Amgen's R&D head leaves for the startup scene, and BMS' commercial chief jumps ship.
Human Longevity CFO/COO departs after scandal; Sangamo loses another top executive; McCann Health fires chief creative for conduct violation and more.
Sangamo's SVP and Chief Technology Officer Michael Holmes is resigning to join an unnamed biotech startup.
Gilead's clinical director joins Nimbus to lead discovery; Immunocore’s CMO jumps to Tmunity; Kite taps Eisai vet to lead CAR-T sales.